MIRA Pharmaceuticals, Inc. Common Stock
Symbol: MIRA (NASDAQ)
1.57
▼ (-4.85%) -0.080
Company Description:
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Key Stats
- Today's Open: $1.56
- Today's High: $1.61
- Today's Low: $1.53
- Today's Volume: 65.35K
- Yesterday Close: $1.65
- Yesterday High: $1.7113
- Yesterday Low: $1.6266
- Yesterday Volume: 246.98K
- Last Min Volume: 0
- Last Min High: $1.573
- Last Min Low: $1.57
- Last Min VWAP: $0
Company Profile
- Name: MIRA Pharmaceuticals, Inc. Common Stock
- Website: https://www.mirapharmaceuticals.com
- Listed Date: 2023-08-03
- Location: MIAMI, FL
- Market Status: Active
- CIK Number: 0001904286
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $30.48M
- Round Lot: 100
- Outstanding Shares: 18.47M
- Asset Type: CS
RECENT FILINGS FOR MIRA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-29 | PRER14A | View |
| 2025-07-29 | 8-K | View |
| 2025-07-28 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-08 | 8-K | View |
| 2025-07-02 | 8-K | View |
| 2025-06-30 | 8-K | View |
| 2025-06-24 | 8-K | View |
| 2025-06-17 | 8-K | View |
| 2025-06-17 | PREM14A | View |
| 2025-06-10 | 3 | View |
| 2025-05-28 | 8-K | View |
| 2025-05-21 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-08 | 8-K | View |
| 2025-05-06 | 8-K | View |
| 2025-04-23 | 8-K | View |
| 2025-04-17 | 10-K/A | View |
| 2025-04-16 | 424B5 | View |
| 2025-04-16 | 8-K | View |
Latest News on MIRA